Cargando…
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines. Despite several issues concerning storage, stability, effective period, and side effects, viral vector vaccines are widely used for the prevention and treatment of various diseases. Recently, viral vector-encapsulated...
Autores principales: | Matsuzaka, Yasunari, Yashiro, Ryu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058598/ https://www.ncbi.nlm.nih.gov/pubmed/36992123 http://dx.doi.org/10.3390/vaccines11030539 |
Ejemplares similares
-
Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023) -
Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications
por: Matsuzaka, Yasunari, et al.
Publicado: (2022) -
Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments
por: Matsuzaka, Yasunari, et al.
Publicado: (2022) -
Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery
por: Matsuzaka, Yasunari, et al.
Publicado: (2022) -
Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)